Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency.
- Resource Type
- Article
- Source
- International Journal of Immunopathology & Pharmacology; 9/14/2020, Vol. 34, p1-10, 10p
- Subject
- Language
- ISSN
- 03946320